Startups
Immatics Biotechnologies
https://immatics.netImmatics Biotechnologies is a biopharmaceutical company focused on the discovery and development of immunotherapy of cancer.
Summary
Total Funding
$180M
- Series E (2017-10-01) $58.0M
- Series D (2013-10-15) $43.7M
- Series C (2010-09-21) $70.8M
- Series B (2005-04-15) $7.5M
Investors
Wellington Partners Series E
dievini Hopp Biotech Holding Series E
Grazia Equity Series B
Full Company Profile
- Access details of the company management, and other intelligence on this company by registering for Seedtable